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Global attention towards antimicrobial resistance (AMR)
and the threat it presents to current and future human
health has soared in the last 2 years (1, 2). A clear marker of
this awakening is the presence of AMR as a priority topic
at the 71st United Nations General Assembly (UNGA) in
late September 2016. This high-level forum is the first to be
held in the post-Millennium Development Goal (MDG)
era, and its agenda reflects the 17 new Sustainable
Development Goals (SDGs). The challenge of AMR is
directly relevant to Goal 3 ‘Good health and well-being’,
but can also be related to Goal 12 ‘Responsible consump-
tion and production’ and Goal 6 ‘Clean water and
sanitation’. The prominence of AMR at the 71st UNGA
is thus not surprising. What is surprising is the compara-
tive neglect of threats from AMR to women and children in
low- and middle-income countries (LMICs) and, specifi-
cally, for the crucial environment of maternity units. Given
the UN Secretary General’s much repeated call to ‘leave no
one behind’ in pursuit of sustainable development by 2030
(3), this neglect is unacceptable. In our article, we call for
joined-up thinking and working to address the current lack
of attention, evidence, and action on the threat of AMR for
maternity units. The benefits of addressing this would be
felt widely, but particularly by the women who become
pregnant and the newborn babies potentially at risk 
estimated, respectively, as 210 million and 140 million in
2015 (4).
Sepsis accounts for around 1015% of deaths among
pregnant or recently-delivered women and among neo-
nates: virtually all of these deaths are preventable and the
vast majority occur in LMICs (4, 5). Options for tackling
sepsis  both preventive and curative  have long been inte-
grated into wider efforts to reduce maternal and neonatal
mortality, as in the latest Global Strategy for Women’s,
Children’s and Adolescents’ Health (6). A defining
moment in the risk to women and babies occurs at the
time of labour and delivery, and this has led to policies and
programmes prioritising skilled care at delivery. Seventy-
five percent of births worldwide are with skilled atten-
dants, largely in institutions. The latest evidence on the
proportion of births occurring in health facilities in
LMICs reveals a marked upward trend over the last
10 years, now passing the 50% tipping-point in most
settings (7) (see Fig. 1). Although the proportion varies
widely between countries, and within countries in terms of
geographic and socio-economic differentials, the overall
increase in coverage is seen as an indicator of success of the
MDG era. However, evidence of the poor care that too
many women and newborn babies receive in maternity
units has also been mounting.
The urgent need to prioritise improvements in quality
of care during delivery, as well as during pregnancy, the
puerperium and beyond, is one of the key messages of the
call to action in the recent Lancet series on maternal
health (8). Quality care has been defined as ‘care which is
Global Health Action
Global Health Action 2016.# 2016 Wendy J. Graham et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to
remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
1
Citation: Glob Health Action 2016, 9: 33381 - http://dx.doi.org/10.3402/gha.v9.33381
(page number not for citation purpose)
D
ow
nl
oa
de
d 
by
 [L
on
do
n S
ch
oo
l o
f H
yg
ien
e &
 T
ro
p M
ed
ici
ne
] a
t 1
2:4
2 2
6 O
cto
be
r 2
01
7 
effective, safe and a good experience for the patient’ (9),
and requires action on six dimensions of quality (10),
including technical skills as well as infrastructure. The
prevalence of healthcare-associated infections (HCAIs)
reflects several of these dimensions, such as missed
opportunities for prevention as well as more rational
and appropriate use of antibiotics (11).
The risk of maternal death from iatrogenic infections at
the time of birth has been known about for centuries (12),
as well as the potential for prevention through hygienic
practices and birth environments. Similarly, the crucial role
of antibiotics in preventing deaths from childbed fever
(puerperal sepsis) has also been well-charted historically;
for example, the contribution to the 80% decline in
maternal mortality in the United Kingdom from 1935 to
1950 (13). This remarkable decline was not, of course, due
solely to antibiotics but also to wider improvements in the
quality of maternity services which ensured women’s care
experiences were indeed effective, safe and good. In other
words, strengthened infection prevention and control
(IPC) was fully integrated into quality improvement,
covering enhanced practices as well as environments.
So have these historic lessons been learnt, adapted, and
applied appropriately to the maternity units in LMICs that
are now the location of most of the world’s births? Is the
full potential from primary prevention of infections at
birth through clean, quality care being realised for mothers
and babies? Unfortunately, evidence from a wide variety of
assessments indicates a huge missed opportunity. AWHO
survey (14) across 54 LMICs revealed that 38% of
healthcare facilities did not have access to basic water
sources and 19% to basic sanitation infrastructure.
A recent detailed analysis of data from the Demographic
and Health Surveys and the Service Provision Assessment
for maternity units across four East African countries
found that less than a third had access to basic water and
sanitation (15). This absence of water, sanitation and
hygiene (WASH) clearly jeopardises birth attendants’
ability to carry-out relevant IPC practices. The reasons
for this poor state of hygiene in maternity units in LMICs
are multifactorial and require concerted action among a
wide variety of stakeholders, from frontline care providers
and cleaners, to estate managers, and to policy-makers and
others ultimately accountable for maternal and newborn
health and survival (16).
And what is the link with AMR? Again history shows
how in high-income countries, a tolerance of poor hygiene
in health institutions coincided with the growing reliance
on antibiotics, which  in turn  perpetuated inappropriate
use and poor drug stewardship, thus contributing to
emerging resistance (17, 18). Moreover, the difficulty of
distinguishing between hospital- or community-acquired
infections, and the scope for risks in both directions,
created ambiguity regarding where action should be
targeted and a perceived need for universal precautions
(19, 20). In LMICs, the comfort blanket of antibiotics
for prophylactic use in clearly indicated cases, such as
operative delivery, can slip seamlessly into routine use for
all deliveries by healthcare workers, partly owing to their
own recognition of the inadequate state of hygiene in
Fig. 1. Positive signage at a maternity unit in Ghana to encourage women to attend for delivery (# 2012 Soapbox Collaborative).
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facilities, and partly to their assumptions about the poor
personal hygiene of women attending for delivery. In India
and Bangladesh, for example, a recent needs assessment
found that 13 of 15 maternity units, public and non-
public, routinely administered antibiotics to all labouring
women, irrespective of a normal or complicated delivery
(21). Recent evidence (22) on the prevention of newborn
infections through use of a single-dose antibiotic to all
women in labour has encouraged further debate on the
risks of prophylactic use as standard care where there is
minimal routine monitoring of resistance and where there
is still considerable room for prevention through improved
hygiene. Moreover, in LMICs where delivery by caesarean
section is increasing, such as in Brazil where levels have
reached 57% of births (23), maternity units may have the
vast majority of women inpatients receiving antibiotics 
both for prophylaxis and for treatment of wound infections
or other clinically-indicated reasons.
So what do we know about the magnitude of AMR on
maternity units? What information is available from
routine monitoring? And what is the strength of the
research evidence-base? In terms of routine data, several
major reports (1, 2, 24) highlight the weaknesses in the
availability, representativeness, and quality of information
on AMR across the globe and across the health sector, but
particularly in LMICs. Maternity units thus suffer from
this generalised problem of a lack of routine information.
As for the magnitude of research, a crude gauge is provided
by searching an established reference database. We used
EMBASE, and limited the search to publications in
English since 2010. To provide an indication of the
maximum potential volume of research, all articles were
included, regardless of the population-base or study type,
and duplicates were not removed. This simple exploration
revealed that the number of references from using broad
search terms for AMR and hospitals was nearly 600 times
greater than the number from using terms for AMR and
maternity units. Among the latter, a trivial proportion of
references specifically mentioned the research context
being LMICs. Accepting the limitations of this crude
approach, and the need for further work to conduct a
robust systematic review, the conclusion is clear  there is
very little published on AMR in maternity units in the very
parts of the world where most births occur and where
quality of care, including primary prevention of infections,
is most lacking.
At the 71st session of UNGA later this month on
AMR, priorities will be set. In the absence of robust
evidence on the situation in maternity units, the threat
from AMR and the opportunities for infection preven-
tion and appropriate antimicrobial stewardship may
simply be ignored, with serious consequences. Together
with the wide variety of agencies pledging their support
for global action on AMR at the UN high-level forum,
such as WaterAid (25), we urge the diverse academic
community  from microbiology, epidemiology, medicine,
pharmacy, health services research, social science, policy
analysis, and many other disciplines  to play their part in
Fig. 2. A crowded maternity unit in Guyana (# 2012 Barry Reinhart/WONDOOR Global Health Program, Courtesy of
Photoshare).
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identifying and implementing a robust, action-oriented
research agenda for AMR specifically targeting maternity
units. Three themes are flagged to illustrate the breadth
of the disciplines and innovation needed:
1. Strengthening tools, metrics, and measurement
systems: Practical tools, such as standardized audit
forms and simple infographics software, are needed
to support the tracking of antibiotic use and to
measure AMR in health service settings in LMICs.
These tools must be sensitive to the limited capacity
of local microbiological laboratories, including
specimen transport, and to the resources needed
for their use. Systems for surveillance of HCAIs 
both infections captured and recorded in facilities
or through community follow-up  require agreed
definitions and innovations in bio-sampling and
informatics in order to establish pathways for
infection and the burden of resistant pathogens;
2. Developing and evaluating interventions: Health
services research and innovative audits are needed
on current standards of IPC in maternity units.
Modalities need to be identified and tested to ensure
that interventions  be these enhanced WASH,
effective bed management to reduce crowding (see
Fig. 2), efficient procurement of essential cleaning
supplies, or better prescribing guidelines and drug
stewardship  are fully integrated into broader
quality improvement processes. The case for robust
intervention trials of alternate drugs and regimes
for the prophylaxis or treatment of maternal and
newborn HCAIs should also be explored;
3. Improving the knowledge base on human behaviour
around AMR: Understanding human behaviour is
key to developing sustainable, effective, and afford-
able interventions to prevent infections and to
mitigate the threat of AMR for maternity units.
Strong, in-depth, social science is essential to under-
stand and influence key preventive behaviours and
practices, such as hand hygiene, infrastructural
maintenance, and facility cleaning.
Women in LMICs have expressed their demand to
deliver in health institutions, with more than half of
births now taking place in maternity units (7). Global
health action is needed to ensure that all women receive
quality care (8) at birth  care that is effective, safe, and a
good experience. Prevention of infections at birth, via
improved WASH and IPC in maternity units is indeed
better than cure  saving lives and costs, and helping to
safeguard antibiotic efficacy. Combining this primary
prevention with essential actions to reduce inappropriate
and unnecessary antibiotic use in maternity units will
ensure we can continue to save women and newborn
babies in the foreseeable future.
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Paper context
The global threat from antimicrobial resistance is increas-
ingly apparent but some at-risk groups are neglected. Sepsis
deaths still occur among mothers and babies, particularly in
low- and middle-income countries. The birth environment is
crucial to preventing infections. Good hygiene at birth
reduces risks and so impacts on the need for antibiotics
and the emergence of resistance. Researchers should help
strengthen the evidence-base to inform a dual strategy of
infection prevention and rational drug use.
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